FDA NDC Directory · JSON-LD · Markdown

Cisatracurium Besylate

NDC 0409-1208 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameCISATRACURIUM BESYLATE
Labeler / ManufacturerHospira, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203238
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsCISATRACURIUM BESYLATE (2 mg/mL)
Marketing started20200324
Package count1

External sources

Source: openFDA. Public-domain (CC0).